66200-59-7

Basic information

• Product Name: 4-Phenyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine
• Synonyms: 4-Phenyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine
• CAS NO: 66200-59-7
• Molecular Formula: C₁₃H₁₃NS
• Molecular Weight: 215.31402
• Mol File: 66200-59-7.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 4-Phenyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Phenyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine(66200-59-7)
• EPA Substance Registry System: 4-Phenyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine(66200-59-7)

Safety Data

• Hazardous Substances Data: 66200-59-7(Hazardous Substances Data)

Upstream product

• 498-62-4 3-thiophene carboxaldehyde 
• 7568-93-6 2-Amino-1-phenylethanol 
• 4561-43-7 2-amino-1-phenylethanol hydrochloride 
• 98-03-3 thiophene-2-carbaldehyde 
• 66200-58-6 N-(2-hydroxy-2-phenethyl)-2-aminomethylthiophene 

Downstream Products

• 68559-70-6 acetyl-6 phenyl-4 dihydro-4,5 6H-thieno<2,3-c>pyridinone-7 
• 68559-65-9 phenyl-4 dihydro-4,5 6H-thieno<2,3-c>pyridinone-7 
• 66200-97-3 6-phenethyl-4-phenyl-4,5,6,7-tetrahydro-thieno[2,3-c]pyridine 
• 68559-54-6 acetyl-6 phenyl-4 tetrahydro-4,5,6,7 thieno<2,3-c>pyridine 

Relevant articles and documents

Rearrangement and Cyclisation of N-(2-Hydroxyphenethyl)-2-aminomethylthiophens

Treatment with acids converted N-(2-hydroxy-2-phenethyl)-2-aminomethylthiophens into thienetetrahydropyridines in good yields; with trifluoroacetic acid the major product was the rearranged 7-phenyl-4,5,6,7-tetrahydrothienopyridine, whereas with po

Thieno [2,3-c] and [3,2-c] pyridines

This invention relates to pyridine derivatives of the formulae: STR1 in which R1 is hydrogen, lower alkyl, aralkyl optionally substituted on the aromatic nucleus with at least a halogen atom or a hydroxy, nitro, amino, cyano, carboxy, alkoxycarbonyl, lower alkyl, lower alkoxy or trifluoromethyl group; R2 is hydrogen or lower alkyl; and R3 is hydrogen or at least a substituent selected from a halogen atom, a hydroxy, lower alkyl and lower alkoxy group, and their pharmaceutically acceptable inorganic or organic acid addition salts. Said compounds have particularly an anti-inflammatory and blood-platelet aggregation inhibiting activity.